4.4 Drug Storage, Delivery & Non-Resident Pharmacy Obligations
Key Takeaways
- Rule 1140-03-.12(1) requires all prescription drugs, controlled substances, devices, and related materials to be stored in an area not accessible to the public.
- Rule 1140-03-.12(5) expressly permits delivery of a prescription to a patient's home or business by an agent of the pharmacy practice site, so courier and home delivery are lawful in Tennessee.
- Hypodermic needles and syringes must be stored out of public access and sold only on proof of medical need, and all insulin preparations must be stored out of public access and sold only by a pharmacist, intern, or technician under direct supervision.
- A non-resident pharmacy must place a toll-free number on the label of each container dispensed to a Tennessee resident and provide pharmacist access at least six days per week and not less than forty hours per week under Rule 1140-01-.08(3)(a)7.
- Rule 1140-03-.09 requires the pharmacist in charge to immediately report to the Board any robbery, embezzlement, theft, burglary, fire, or disaster resulting in loss of prescription drugs, controlled substances, devices, or related materials, with a list and amounts.
4.4 Drug Storage, Delivery & Non-Resident Pharmacy Obligations
Quick Answer: Tennessee's storage and delivery rule is Tenn. Comp. R. & Regs. 1140-03-.12. Paragraph (1) requires all prescription drugs, controlled substances, devices, and related materials to be stored "in an area not accessible to the public." Paragraphs (3) and (4) add two product-specific restrictions that are heavily tested: injection devices must be stored out of public access and sold only on proof of medical need, and all insulin preparations must be stored out of public access and sold only by a pharmacist, or by an intern or technician under the direct supervision of a pharmacist. Paragraph (5) supplies the affirmative delivery authority: "Nothing in this section prohibits delivery of a prescription to a patient's home or business by an agent of the pharmacy practice site." For pharmacies located outside Tennessee, Rule 1140-01-.08(3)(a) sets ten licensure conditions, including the toll-free pharmacist line and a Tennessee-licensed pharmacist in charge.
1. Storage: The Public-Access Line
Tennessee's storage rule is short and absolute at its core. Everything the pharmacy holds as prescription stock lives behind the public-access line.
| Rule 1140-03-.12 | Requirement | Who may sell |
|---|---|---|
| (1) | All prescription drugs, controlled substances, devices, and related materials stored in an area not accessible to the public | — |
| (2) | A controlled substance that is not a prescription drug under the FDCA may be dispensed without a prescription if the pharmacist complies with 21 CFR § 1306.32 and other applicable law | Pharmacist |
| (3) | Instruments and devices intended for injection of any substance through the skin stored out of public access; sold only on proof of medical need | Pharmacist, or intern or technician under direct supervision |
| (4) | All insulin preparations stored out of public access | Pharmacist, or intern or technician under direct supervision |
| (5) | Delivery to a patient's home or business by an agent of the pharmacy practice site is not prohibited | — |
Two points about paragraph (4) surprise candidates. First, it reaches all insulin preparations, including products that are otherwise sold over the counter — Tennessee removes them from open shelving. Second, the sale itself is restricted to licensed or registered pharmacy personnel; a front-end cashier may not ring an insulin sale as a general merchandise transaction.
Paragraph (3) is Tennessee's needle and syringe provision. The trigger is functional — an instrument or device "intended for the injection of any substance through the skin" — and the gate is proof of medical need, assessed by the pharmacist. Read it alongside Rule 1140-03-.12(1): the devices are behind the counter before the proof-of-need question is ever reached.
2. Delivery of Drugs — Competency 4.3
The NABP Competency Statements devote competency 4.3 to "delivery of drugs." Tennessee's authority is a single clause, but it does real work: it confirms that home and workplace delivery by a pharmacy agent is lawful, which in turn makes courier programs, staff delivery routes, and contracted delivery services permissible without a separate Board authorization.
Delivery does not, however, suspend any of the pharmacy's other duties. Three follow the package out the door:
- Counseling. Because the patient is not present, Rule 1140-03-.01(1)(a) requires a reasonable effort to counsel through alternative means — in practice, a documented telephone contact.
- Labeling. The full Rule 1140-03-.06 label travels with the product, including the pharmacy's telephone number and any appropriate advisory label.
- Storage integrity. Cold-chain products delivered by courier must arrive within their labeled storage range; a delivered product that has been temperature-abused is adulterated and cannot be dispensed or returned to stock (see Rule 1140-03-.10(1)).
What Delivery Is Not
Delivery under paragraph (5) is not a licence to accept orders anywhere. Rule 1140-03-.03(9) provides that medical and prescription orders "cannot be accepted, solicited, collected or advertised at any location other than a pharmacy practice site for which a license has been issued by the Board," and that the licensed site must be actively engaged in compounding and dispensing. The rule carves out one narrow case: an entity or non-licensed site that does not dispense drugs directly to patients may accept, solicit, and collect prescriptions for the purpose of medication therapy management or other consultative services related to drug therapy and patient care. A drop-box at a gym or a physician office collection point for dispensing purposes fails this rule.
3. Centralized Prescription Processing — Rule 1140-03-.16
A pharmacy may perform or outsource centralized prescription processing to another pharmacy only if three threshold criteria are met:
- Both pharmacies are licensed by the State of Tennessee.
- Both share a common electronic file, or both have the technology to access the information necessary to fill or refill the order.
- Both have the same owner; or, if ownership differs, the pharmacies have entered a written contract stating the services each will provide, the responsibilities of each, and how each will comply with federal and state law.
The pharmacy performing or contracting for the service must maintain a policy and procedures manual and provide it to the Board upon request. Rule 1140-03-.16(2) specifies what the manual must include:
┌─────────────────────────────────────────────────────────────────────────────┐
│ REQUIRED CONTENTS — CENTRALIZED PROCESSING P&P MANUAL │
├─────────────────────────────────────────────────────────────────────────────┤
│ (a) How the pharmacies will comply with federal and state law and rules. │
│ (b) Maintenance of records identifying the RESPONSIBLE PHARMACIST(S) in │
│ the dispensing process. │
│ (c) A mechanism for tracking the order during EACH STEP of dispensing: │
│ 1. A mechanism to identify ALL pharmacies involved in dispensing the │
│ order ON THE PRESCRIPTION LABEL; │
│ 2. Adequate security measures protecting confidentiality and integrity │
│ of patient information; and │
│ 3. A quality assurance program to objectively and systematically │
│ monitor and evaluate quality of patient care, identify problems, │
│ and resolve them. │
│ (d) Pharmacies not physically located in Tennessee shall comply with │
│ T.C.A. Title 63, Chapter 10 and the Board's rules. │
└─────────────────────────────────────────────────────────────────────────────┘
Subparagraph (c)1 is the most quotable line in the rule: the label itself must identify every pharmacy involved in dispensing the order.
4. Non-Resident (Out-of-State) Pharmacy Practice Sites — Rule 1140-01-.08(3)(a)
No out-of-state pharmacy practice site may conduct business in Tennessee until it obtains a Tennessee license. Rule 1140-01-.08(3)(a) then imposes ten standing conditions. The ones that generate exam items are:
| # | Condition |
|---|---|
| 1 | File an application listing the site address, owner or partners or corporate officers, and all pharmacists who practice at the site; notify the director in writing within 30 days of any change to that information |
| 3 | Maintain at all times a current permit, license, or registration in the state where the site is physically located |
| 4 | Submit the most recent inspection report from the home-state regulator, and each subsequent report; an out-of-state site engaged in compounding must provide an inspection performed within the previous twelve months; an FDA inspection, or an NABP inspection in lieu of the home-state agency's, is acceptable |
| 5–6 | Maintain records of orders dispensed to Tennessee residents and keep them readily retrievable from other records |
| 7 | Provide pharmacist access by toll-free telephone during regular hours, not less than six days per week nor less than forty hours per week, and place the toll-free number on the label affixed to the dispensing container for each prescription dispensed to a Tennessee resident |
| 8 | Designate a pharmacist in charge responsible for compliance who holds a current Tennessee pharmacist license |
| 9 | Comply with the Tennessee requirements for patient counseling, patient profiling, drug regimen review, and pharmaceutical care at Rule 1140-03-.01 |
Condition 8 is the one candidates most often get wrong: the non-resident pharmacy's PIC must hold a Tennessee license, not merely a license in the home state.
5. Loss of Drugs in Storage or Transit — Rule 1140-03-.09
Rule 1140-03-.09 imposes a reporting duty distinct from, and broader than, the DEA's:
"The pharmacist in charge shall immediately report to the board any robbery, embezzlement, theft, burglary, or fire or disaster resulting in a loss of prescription drugs, or controlled substances or medical devices or related materials. The report shall include a list, including amounts, of such … lost or damaged."
| Dimension | Tennessee Rule 1140-03-.09 | Federal 21 CFR § 1301.76(b) |
|---|---|---|
| Scope of product | Prescription drugs, controlled substances, medical devices, and related materials | Controlled substances only |
| Trigger | Robbery, embezzlement, theft, burglary, fire or disaster | Theft or significant loss |
| Timing | Immediately | Written notice within one business day of discovery, then DEA Form 106 |
| Content | A list including amounts lost or damaged | Form 106 detail |
A flood that destroys non-controlled inventory triggers no federal report at all, but does trigger the Tennessee report. Conversely, a significant controlled substance shortage discovered on audit triggers both.
6. Practical Exam Scenarios
Scenario 1: Insulin on the Front-End Shelf
Case: A grocery-store pharmacy stocks regular human insulin in the refrigerated case in the dairy aisle so customers can pick it up after hours when the pharmacy is closed. Legal Analysis: This violates Rule 1140-03-.12(4). All insulin preparations must be stored in an area not accessible to the public and sold only by a pharmacist, or by a pharmacy intern or pharmacy technician under the direct supervision of a pharmacist. The after-hours convenience rationale is irrelevant, and the arrangement independently conflicts with Rule 1140-01-.13(7), which bars the prescription department from being open for business without a pharmacist present.
Scenario 2: The Central Fill Label
Case: A Nashville pharmacy contracts with an unaffiliated Memphis pharmacy for centralized processing. Both are Tennessee-licensed and share a real-time database, and both signed a written services contract. The dispensing label names only the Nashville site. Legal Analysis: The ownership and technology criteria are satisfied — Rule 1140-03-.16(1) accepts common ownership or a written contract. The label is the defect: Rule 1140-03-.16(2)(c)1 requires a mechanism to identify all pharmacies involved in dispensing the order on the prescription label.
Scenario 3: Out-of-State Compounder
Case: An Alabama sterile compounding pharmacy applies for a Tennessee non-resident license and submits an Alabama Board inspection report dated 26 months ago, designating its Alabama-licensed director of pharmacy as PIC. Legal Analysis: Two conditions fail. Rule 1140-01-.08(3)(a)4(i) requires an out-of-state site engaged in compounding to provide an inspection performed within the previous twelve months — an FDA inspection or an NABP inspection would also be acceptable, but a 26-month-old state report is not. And Rule 1140-01-.08(3)(a)8 requires the designated pharmacist in charge to hold a current Tennessee pharmacist license.
Under Tenn. Comp. R. & Regs. 1140-03-.12, which statement about insulin and hypodermic needles in a Tennessee pharmacy is correct?
Two Tennessee-licensed pharmacies under different ownership want to share centralized prescription processing. Under Rule 1140-03-.16, what makes the arrangement lawful?
A pharmacy physically located in Georgia is licensed as a Tennessee non-resident pharmacy practice site. Which requirement does Tenn. Comp. R. & Regs. 1140-01-.08(3)(a) impose?
An overnight fire destroys a portion of a Tennessee pharmacy's inventory, including non-controlled legend drugs and a small quantity of Schedule IV stock. What reporting is required?